T. Rowe Price Associates’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,971
| Closed | -$206K | – | 2921 |
|
|
2023
Q3 | $206K | Hold |
16,971
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q2 | $180K | Sell |
16,971
-9,923
| -37% | -$105K | ﹤0.01% | 2560 |
|
|
2023
Q1 | $265K | Hold |
26,894
| – | – | ﹤0.01% | 2405 |
|
|
2022
Q4 | $396K | Buy |
26,894
+8,567
| +47% | +$126K | ﹤0.01% | 2247 |
|
|
2022
Q3 | $223K | Sell |
18,327
-1,917,113
| -99% | -$23.3M | ﹤0.01% | 2502 |
|
|
2022
Q2 | $27.1M | Sell |
1,935,440
-152,905
| -7% | -$2.14M | ﹤0.01% | 1078 |
|
|
2022
Q1 | $29.7M | Sell |
2,088,345
-78,477
| -4% | -$1.12M | ﹤0.01% | 1130 |
|
|
2021
Q4 | $45.7M | Buy |
2,166,822
+250,849
| +13% | +$5.29M | ﹤0.01% | 1042 |
|
|
2021
Q3 | $50.3M | Buy |
1,915,973
+739,969
| +63% | +$19.4M | ﹤0.01% | 1011 |
|
|
2021
Q2 | $36.7M | Buy |
1,176,004
+1,121,157
| +2,044% | +$35M | ﹤0.01% | 1134 |
|
|
2021
Q1 | $1.68M | Buy |
54,847
+37,994
| +225% | +$1.17M | ﹤0.01% | 1798 |
|
|
2020
Q4 | $578K | Buy |
+16,853
| New | +$578K | ﹤0.01% | 2181 |
|